Genetic polymorphisms associated with anti-malarial antibody levels in a low and unstable malaria transmission area in southern Sri Lanka by Rajika L Dewasurendra et al.
Dewasurendra et al. Malaria Journal 2012, 11:281
http://www.malariajournal.com/content/11/1/281RESEARCH Open AccessGenetic polymorphisms associated with
anti-malarial antibody levels in a low and
unstable malaria transmission area in southern
Sri Lanka
Rajika L Dewasurendra1, Prapat Suriyaphol2, Sumadhya D Fernando1, Richard Carter3,
Kirk Rockett4, Patrick Corran5, Dominic Kwiatkowski4,6 and Nadira D Karunaweera1*
in collaboration with the 7 MalariaGEN ConsortiumAbstract
Background: The incidence of malaria in Sri Lanka has significantly declined in recent years. Similar trends were
seen in Kataragama, a known malaria endemic location within the southern province of the country, over the past
five years. This is a descriptive study of anti-malarial antibody levels and selected host genetic mutations in
residents of Kataragama, under low malaria transmission conditions.
Methods: Sera were collected from 1,011 individuals residing in Kataragama and anti-malarial antibodies and total
IgE levels were measured by a standardized ELISA technique. Host DNA was extracted and used for genotyping of
selected SNPs in known genes associated with malaria. The antibody levels were analysed in relation to the past
history of malaria (during past 10 years), age, sex, the location of residence within Kataragama and selected host
genetic markers.
Results: A significant increase in antibodies against Plasmodium falciparum antigens AMA1, MSP2, NANP and
Plasmodium vivax antigen MSP1 in individuals with past history of malaria were observed when compared to those
who did not. A marked increase of anti-MSP1(Pf) and anti-AMA1(Pv) was also evident in individuals between
45–59 years (when compared to other age groups). Allele frequencies for two SNPs in genes that code for IL-13
and TRIM-5 were found to be significantly different between those who have experienced one or more malaria
attacks within past 10 years and those who did not. When antibody levels were classified into a low-high binary
trait, significant associations were found with four SNPs for anti-AMA1(Pf); two SNPs for anti-MSP1(Pf); eight SNPs for
anti-NANP(Pf); three SNPs for anti-AMA1(Pv); seven SNPs for anti-MSP1(Pv); and nine SNPs for total IgE. Eleven of
these SNPs with significant associations with anti-malarial antibody levels were found to be non–synonymous.
Conclusions: Evidence is suggestive of an age–acquired immunity in this study population in spite of low malaria
transmission levels. Several SNPs were in linkage disequilibrium and had a significant association with elevated
antibody levels, suggesting that these host genetic mutations might have an individual or collective effect on
inducing or/and maintaining high anti–malarial antibody levels.
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Malaria used to be a major public health problem in Sri
Lanka with almost 0.3 million positive cases reported
10 years ago [1]. However, a significant reduction of
malaria incidence was observed after the year 2002 due
to many reasons, including the modifications introduced
to the National Malaria Control Programme (in 1993) to
be in line with the New Global Malaria Control Strategy
recommended by the World Health Organization. In
this context, Sri Lanka has moved to a phase of “elimin-
ation” of malaria [2]. The number of cases reported from
the Moneragala District, Sri Lanka, which was consid-
ered an endemic area for both vivax and falciparum mal-
aria, has also dramatically reduced since 2001 (Table 1).
A previous study carried out in this locality to quantify
genetic and non-genetic contributions to malaria infec-
tions (by pedigree analysis of longitudinal data) has
shown that host genetic factors do contribute to the
variation in the frequency and intensity of clinical epi-
sodes of malaria in this population [3]. This current
study was planned as a follow-up in order to investigate
the profile of 6 selected anti-malarial antibodies of these
residents and study its association with host genetic
mutations in selected genes.
The immune status of the residents living in areas with
low malaria transmission and its relationship with other
demographic characteristics has been reported from
elsewhere previously [4,5]. Many studies have also been
conducted to evaluate the role of host genetic factors
associated with serological responses. Luoni et al.
reported the association between the T allele of the IL4-
524 polymorphism and elevated antibody levels against
malaria antigens in West Africa [6]. Similar results were
obtained in further studies in Burkina Faso and Ghana
showing association of IL4-589 C/T allele with increasedTable 1 Malaria incidence reported from Moneragala District
(MRS) – Kataragama (1998 – 2008)
Year Malaria incidence reported from Moneragala District Mal
P. v. (+) P. f. (+) Total
1998 20924 3124 24048
1999 35471 7202 42673
2000 30752 10133 40885
2001 3246 459 3705
2002 624 181 805
2003 350 42 392
2004 136 15 151
2005 16 1 17
2006 1 0 1
2007 6 0 6
2008 3 1 4
Source of data: Anti-malaria campaign, Ministry of Healthcare and Nutrition, Sri Lanlevels of anti-Plasmodium falciparum IgG antibodies
and total IgE levels [7,8].
This study looks at the immune status and its relation-
ship with demographic changes and selected host gen-
etic markers of residents in eight villages in the
Moneragala district, Sri Lanka where the malaria inci-
dence has declined steadily over the past decade.
Methods
Ethical clearance
Ethical clearance for this study was granted by the Ethics
Review Committee, Faculty of Medicine, University of
Colombo. One thousand and eleven individuals over
14 years of age and who gave written consent to partici-
pate in the study were recruited to the study. Proxy con-
sent was obtained for the young participants (aged 14–
18 years) from their parents or the guardian/s.
Study area
This study was conducted in eight adjacent villages in
Kataragama Medical Officer of Health (MOH) division
in the district of Moneragala [1]. Kataragama is an area
in the dry lowland coastal plains of south-east Sri Lanka,
where the malaria situation is considered “unstable” and
low within the last decade.
Recruitment of individuals for the study
The number of houses in each village and number of
individuals in each house were listed, based on previ-
ous census records maintained by the field research
facility at the Malaria Research Station, Kataragama
[1]. Each house and each individual living in that
house was given a unique number for identification.
The study subjects were visited during four consecu-
tive visits to the area between December 2006 andand from the study areas to Malaria Research Station
aria incidence reported from the study area to MRS – Kataragama












ka and database maintained at MRS.
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blood samples for DNA extraction, sera and thin/thick
blood smears.Sample and data collection
Five mL of blood was collected from all study subjects
to normal tubes for serum samples and for EDTA–
coated tubes for DNA extraction. Thin and thick blood
smears were prepared for examination for the presence
of parasites in the blood. Each tube and the corre-
sponding slides were labeled according to the serial
number given for each individual. Data on age, sex,
history of previous clinical malaria during the past
10 years and information on the use of bed nets were
recorded.Serum separation and ELISA
Serum was separated from the clotted blood samples
by centrifugation (12,000 rpm for eight minutes) and
analysed for six anti-malarial antibodies (ie, anti-
AMA1, anti-MSP1, anti-MSP2, anti-NANP, for P. falcip-
arum, anti-AMA1 and anti-MSP1 for Plasmodium vivax)
and total IgE with the levels determined using standard
ELISA technique. Fifty μL of each antigen at a dilution of
0.5 μg/mL (for AMA1 (3D7), MSP2 (3D7) and IgE) or
1 μg/mL (for MSP1 (Wellcome genotype) and NANP
[(NANP)4] were coated on ELISA plates (Immulon4
ELISA plates/Dynatech) and were incubated at 4°C over-
night. The plates were washed with a solution of PBS and
0.05% Tween20 (PBS/T) and 200 μL of blocking solution
(2% skimmed milk in PBS/T) were added before incubat-
ing the plates for three hours in ambient temperature.
Serum samples were added in duplicates after washing the
incubated plates with PBS/T. These were incubated over-
night at 4°C. Plates were washed in PBS/T and 50 μL of
horseradish peroxidase – conjugated rabbit anti-human
IgG (DAKO) diluted 1/5,000 in PBS/T were added and
incubated for three hours at room temperature. The plates
were again washed with PBS/T and OPD substrate solu-
tion (100 μL/well) was added and left at room
temperature for 10–15 minutes for the assay to develop.
2 M H2SO4 (25 μL/well) was added to stop the reaction
and the plates were read at 492 nm in an ELISA reader
(Additional file 1 OD values). The cut-off value of the
assay was determined by calculating the arithmetic mean
of the absorbance of negative control samples obtained
from European individuals who had never been exposed
to malaria and adding three standard deviations to that
value (mean OD+3SD). Using standard positive and
negative controls, positive–negative threshold baseline
was constructed using OD values obtained upon ELISA
and was used for calculation of the observed antibody
titres as described by Snyder et al. in 1983 [9].DNA extraction and genotyping
DNA was extracted from whole blood (2.5 mL) collected
in to EDTA tubes using Nucleon BACC2 commercial
DNA extraction kit [Gen-Probe Life Sciences, Tepnel
Research Products & Services, Manchester, UK]. Five ng
of gDNA was whole-genome amplified by primer-
extension pre-amplification (PEP) using N15 primers
(Sigma, UK) and Biotaq (Bioline, UK) polymerase as pre-
viously described by Zhang et al. [10]. Single nucleotide
polymorphisms (SNPs) were assayed on the SequenomW
iPLEX platform according to manufacturer’s instruction
using diluted PEP DNA (1:10). Genotype calls were
made using the SequenomW Typer v4.03 software [11].
Screening for malaria infection
Blood samples were screened for malaria infection by
microscopic examination of stained thin and thick blood
smears by trained microscopists.
Data analysis
Antibody levels were analysed in relation to age, gender
and the history of malaria. For the genetic analysis a
total of 170 SNPs in 62 genes were genotyped (Add-
itional File 2 SNPs). This included 65 SNPs with known
associations with malaria infection/disease severity.
SNPs were filtered according to the following criteria:
SNPs with less than 95% genotype call, not in Hardy-
Weinberg Equilibrium (p < 0.05), or monomorphic were
excluded from further analysis. Individuals who had less
than 95% of the SNPs genotyped were also excluded
from further analysis. After quality control of SNPs and
samples, 118 SNPs in 1,008 individuals were selected for
further analysis.
Data were analysed using SPSS V 13.0, R software
package for statistical analysis (2.6.1) and MINITAB
14.0. Kruskall–Wallis test and Mann–Whitney U tests
were used to compare and study associations and Fish-
er’s Exact and Chi-squared tests were also used for geno-
type analysis. Significance of SNPs was confirmed by
generation of q values using the software QVALUE
(V1.0) [12]. Linkage disequilibrium (LD) plots for the 19
genes where the 23 significant SNPs were located were
generated using Haploview (V4.2).
Results
Characteristics of the population
Ages ranged from 14 to 89 years with approximately
equal numbers of males and females (514:497). Over
99% of the population belonged to one ethnic group
(Sinhala) with only seven belonging to Tamil ethnicity.
The majority of individuals (>95%) used bed nets. Only
18.4% of individuals (186/1,011) have had clinical mal-
aria within the past 10 years and none within the past
five years (Table 2). At the time of sample collection,
Table 2 Demographic characteristics, history of disease
and seropositivity of the study population




14 – 29 380 (37.6)
30 – 44 307 (30.4)
45 – 59 234 (23.1)






History of malaria within past 10 years
Yes 186 (18.4)
No 532 (52.6)
Cannot remember 293 (29.0)
History of malaria within past five years
Yes 0 (0.0)
No 1,011 (100.0)
Cannot remember 0 (0.0)
Bed net use in 1992/94
No 111 (10.9)
Yes 896 (88.6)
Cannot remember 4 (0.3)
Bed net use last night
No 40 (4.0)
Yes 968 (95.7)






Total IgE 848 (83.88)
Pv_AMA1 1,007 (99.60)
Pv_MSP1 981 (97.03)
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parasites in all subjects.Results of serological investigations
Greater than 80% and >97% of participants were sero-
positive for P. falciparum and P. vivax respectively
(Table 2). The study population was divided into three
groups based on the participants’ past history of clinical
malaria within the past 10 years (Table 2). Anti-AMA1
(Pf ) (p = 0.004), anti-MSP2 (Pf ) (p = 0.027), anti-NANP(Pf ) (p = 0.002) and anti-MSP1 (Pv) (p = 0.003) levels
were significantly higher in people who have had one or
more clinical malaria episodes within the past 10 years,
when compared to those who gave no evidence of clin-
ical malaria during past 10 years (Table 3).
Total study population was categorized into five age-
groups based on their ages at the time of collection of
serum (Table 2). The three age groups comprised 14–29,
30–44, and 45–59 years old and were almost equally
represented (37.6%; 30.4%, 23.1% respectively) while a
relatively lower proportion of subjects represented the
>60-year-old age group. A high level of anti-MSP1 (Pf )
(p = 0.001) and of anti-AMA1 (Pv) (p < 0.001) was
observed in the 45–59 year old age group (when com-
pared to other age groups) (Table 4).
The levels of all six anti-malarial antibodies were com-
parable between males and females (Table 3). However,
the total IgE concentration between males and females
were seen to be significantly different (p < 0.001) with
the median concentration of total IgE in males
(5,719.66 ng/mL) being significantly higher when com-
pared to females (3,298.72 ng/mL).
Antibody levels were classified into a low-high binary
trait using a cut-off of 5,000 IU/mL by ploting a histogram
of antibody levels transformed in to logarithm base 10.
The threshold was set at 10 for the histogram, as there
was a clear separation between two peaks at this point.
The residents of Akkarawissa consistently showed
overall higher antibody levels compared to the residents
in all other villages (Figure 1A-1B) for not only all the
anti-malarial antibodies but IgE as well. These high over-
all levels were contributed by >60% of the village partic-
pants who had high antibody levels (>5,000 IU/ml), in
contrast to <10% of individuals from the other villages.
Relationships of serological data and genetic data
Genetic data was analysed against the categorical classi-
fication of antibody data using a cut-off of 5,000 IU/ml
to define the low and high antibody groups. Significant
association was found with four SNPs and anti-AMA1
(Pf ); two SNPs and anti-MSP1(Pf ) (none for anti-MSP2
(Pf )); eight SNPs and anti-NANP(Pf ); two SNPs and
anti-AMA1(Pv); six SNPs and anti-MSP1(Pv); and seven
SNPs and IgE (Table 5). Eleven SNPs out of these 28
were located in genes that code for interleukins, ie, IL4,
IL10, IL13 and IL22. Most of these markers within the
interleukin genes were seen to be in association with
high levels of P. falciparum anti-malarial antibodies and
five out of seven host genetic markers, which were sig-
nificantly associated with high IgE levels, were located in
IL4 and IL10 genes (with the other two being located in
GBP7 and DERL3 genes).
The only interleukin-associated host genetic marker
that was significantly associated with high levels of P.
Table 3 Comparison of median antibody levels of people with and without recent history of malaria and between the
sexes (Group A- People with no history of disease within past 10 years, Group B-People with history of malaria disease
within past 10 years) 293 individuals who stated ‘did not remember’ having a malaria attack were excluded in this
specific analysis
Median anti-malarial antibody levels and total IgE levels (Q1-Q3) (International Units per microlitre except
IgE levels measured in ng/mL)
Anti-AMA1_Pf Anti-MSP1_Pf Anti-MSP2_Pf Anti-NANP_Pf Total IgE Anti- AMA1_Pv Anti- MSP1_Pv
A (n = 532) 531.05 1450.15 1126.80 3390.35 4390.40 3356.15 2190.60
(211.96-1587.54) (589.35-3092.42) (516.52-2893.34) (1878.68-6233.46) (1850.20-8572.42) (1407.27-9834.10) (1113.22-5902.23)
B (n = 186) 885.10 1619.40 1492.45 4460.45 4163.30 3662.70 3559.70
(255.78-1972.92) (603.70-3420.35) (637.78-4450.73) (2344.25-8624.20) (1467.97-8258.32) (1559.33-9297.81) (1332.49-8794.58)




592.43 1597.69 1340.89 3479.23 5719.66 3166.38 2386.78




624.68 1501.08 1214.67 3585.46 3298.72 3691.38 2326.02
(200.56-1958.36) (587.94-3349.18) (519.17-3369.79) (1913.57-6683.77) (1189.41-5921.31) (1591.25-10161.87) (1122.44-6756.56)
p value 0.791 0.493 0.865 0.476 <0.001* 0.056 0.983
Q1-Q3 (1st quartile-3rd quartile).
Significant values [*Mann Whitney U test].
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is a coding SNP in IL13. The SNP coding for the
sickle-cell variant (HbS or rs334), which is situated in
HBB was significantly associated with high antibody
levels against both AMA1 and NANP of P. falciparum
antigens. It was interesting to note that the majority
of SNPs were segregated on a few selected chromo-
somes with eight and 11 SNPs out of 28 found within
genes located on chromosome 1 and chromosome 5
respectively. However, taken together, none of the
SNPs had significant association with elevated levels
of all tested antibodies (Chi-Squared test, RegressionTable 4 Median levels of the six anti-malarial antibodies and
population (a cross-section of the population from age >14 y
Median anti-malarial antibody levels and total IgE levels (Q
measured in ng/mL)
Age group MSP1_Pf MSP2_Pf AMA1_Pf NANP
14-29 1319.27 1088.68 534.77 3594.7
(476.78-3107.21) (452.85-3329.50) (186.71-1918.41) (1942.
30-44 1350.6 1250.91 593.89 3212.4
(614.17-3163.44) (601.21-3291.47) (203.75-1741.98) (1890.
45-59 2037.26* 1628.88 691.92 3812.2
(948.82-4132.19) (652.23-3847.64) (283.74-1795.61) (1985.
60-75 1733.84 1128.77 592.54 3921.3
(889.44-3703.19) (564.93-2823.93) (248.00-1609.49) (2088.
>75 1729.72 1177.5 778.67 2967.5
(1287.32-3077.00) (716.23-2667.64) (325.45-1708.98) (2538.
p 0.001 0.372 0.406 0.477
Anti-MSP1 (Pf)* and anti-AMA1 (Pv)** levels were significantly higher in the 45–59 y
performing Kruskal-Wallis test for association between median antibody levels of di
Q1-Q3 (1st quartile-3rd quartile).analysis, p < 0.05). Nine SNPs, which had significant
associations with elevated antibody levels were found to
be synonymous in their function (Table 4), which
included all significant SNPs located in interleukin
genes. However, some of the studied SNPs, e.g. those
located in FCGR2a, SLC22A4, TLR4, ICAM1 and HBS
genes, were non-synonymous in function (Table 5). Al-
lele frequencies in two SNPs (rs20541 and rs7935564) in
two genes, ie, IL13 and TRIM5 were found to be signifi-
cantly different (p = 0.038) between those with past his-
tory of malaria (one or more clinical malaria attacks
during last 10 years, i.e. malaria-susceptible individuals)total IgE levels in different age groups in the study
rs grouped into five age groups)
1-Q3) (International Units per microlitre except IgE levels
_Pf IgE AMA1_Pv MSP1_Pv
9 3963.39 2766.07 2194.75
41-7020.00) (1479.99-8132.72) (1202.57-8831.96) (939.18-7030.56)
7 4291.16 3209.42 2264.82
03-6015.25) (1880.78-8081.28) (1598.00-8223.37) (1245.76-5786.05)
4 4935.19 5174.55** 2752.59
26-9252.97) (2013.94-9753.25) (2067.67-14464.98) (1471.60-8346.44)
7 4469.11 3851.21 2670.22
93-7266.04) (2106.46-6952.20) (1842.01-13399.11) (1454.50-6004.46)
3 4867.95 4677.19 1849.98
34-4836.03) (1826.49-7184.74) (2810.53-8257.18) (1125.00-4363.06)
0.33 p< 0.01 0.142
ear age group (p = 0.001, p < 0.001 respectively – p values obtained by
fferent age groups).
Figure 1 Median of anti-malarial antibodies and total IgE levels of residents of the eight villages in Kataragama, Monereagala District
included in the study: Akkarawissa, Angunnara, Karawile, Kohombadigana, New Buttala Road, Old Buttala Road, Sella Kataragama and
Thanamalwila. The residents of Akkarawissa showed higher levels of all six anti-malarial antibodies compared to the residents of other seven
villages.
Dewasurendra et al. Malaria Journal 2012, 11:281 Page 6 of 10
http://www.malariajournal.com/content/11/1/281and people without past history, i.e. apparently protected
from malaria (Chi-Squared test p = 0.036).
Significance of allele frequencies of SNPs was further
confirmed by the calculation of q values for each p value
using the software QVALUE (QVALUE Version 1.0;
Alan Dabney and John D Storey; pi0 =1, FDR level 0.05).
Linkage disequilibrium
Two SNPs (rs1800872 and rs1800871), which were sig-
nificant for elevated levels of anti-NANP (Pf) and total
IgE, were in linkage disequilibrium (D’= 1.00, LOD=
334.61, r2 = 1.00)(Figure 2a-2c). These two SNPs were
also in LD with rs1518110 (D’= 1.00, LOD=278.77,
r2 = 0.87) which was significant for raised levels of both
anti-NANP(Pf ) and total IgE. In chromosome 5, high
linkage disequilibrium could be seen between SNPs
rs1801033 and rs1881457 (D’= 0.858, LOD=164.96,r2 = 0.646), rs18811457 and rs2243250 (D’= 0.93, LOD=
206.85, r2 = 0.754), rs25882 and rs2706348 (D’= 0.86,
LOD=146.5, r2 = 0.667). Similarly high LD could also be
seen between rs1801033 and rs22443250 (D’= 0.689,
LOD=107.26, r2 = 0.472), rs2706348 and rs272867
(D’= 0.662, LOD=54.79, r2 = 0.279).
Discussion
The study site, Kataragama is located within the
malarial-endemic zone of Sri Lanka. Although most of
the participants have apparently not been exposed to
malaria for over a period of 10 years due to low intensity
of malaria transmission, the overall prevalence of anti-
malarial antibodies were seen to be very high. This
might be a result of asymptomatic infections that may
prevail in the area and/or prolonged memory of immune
cells/factors, which would need to be confirmed
Table 5 Function and details of identification of the significant SNPs associated with high levels of each anti-malarial
antibody levels and total IgE levels
Antibody Significant SNPs Chromosome (Position) Gene Allele associated p Function
AMA1_Pf rs25882 5 (131411460) CSF2 T 0.039 NS
rs1881457 5 (131992409) IL13 T 0.047 S
rs334 11 (5248232) HBB A 0.008 NS
rs1799969 19 (10394792) ICAM1 G 0.043 NS
MSP1_Pf rs2706348 5 (131933709) RAD50 G 0.039
rs2227478 12 (68648622) IL22 A 0.043 S
MSP2 NONE
NANP rs7537937 1 (89582690) GBP7 C 0.003 NS
rs1800872 1 (206946407) IL10 T 0.033 S
rs1800871 1 (206946634) IL10 A 0.031 S
rs25887 5 (131416061) CSF2 C 0.013 NS
rs156029 5 (131532634) P4HA2 A 0.0007
rs272867 5 (131681057) SLC22A4 G 0.039
rs1881457 5 (131992409) IL13 T 0.019 S
rs334 11 (5248232) HBB A 0.001 NS
AMA1_Pv rs4986790 9 (120475302) TLR4 A 0.039 NS
rs1801033 5 (41199959) C6 A 0.049 NS
MSP1_Pv rs1801274 1 (161479745) FCGR2a T 0.018 NS
rs156029 5 (131532634) P4HA2 A 0.016
rs848 5 (131996500) IL13 G 0.030 S
rs2242665 6 (31821494) CTL4 A 0.015 NS
rs7935564 11 (5718517) TRIM5 A 0.025 NS
rs10775349 16 (4079823) ADCY9 G 0.042 S
Total IgE rs7537937 1 (89582690) GBP7 C 0.024 NS
rs1518110 1 (206944861) IL10 C 0.002 S
rs1800872 1 (206946407) IL10 T 0.001 S
rs1800871 1 (206946634) IL10 A 0.001 S
rs2243250 5 (132009154) IL4 C 0.023 S
rs2243270 5 (132014109) IL4 T 0.039 S
rs3177244 22 (24179132) DERL3 G 0.043 NS
NS: non-synonymous, S: synonymous.
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subjects were considered as un-infected, based on
blood-smear examination for malaria, use of more sensi-
tive assays, e.g. PCR, could have helped to detect the
presence of a sub-microscopic parasitaemia, if present.
However, all individuals showed evidence of previous ex-
posure to malaria when screened for anti-malarial anti-
bodies. The anti-malarial antibody levels anti-AMA1
(Pf ), MSP2 (Pf ), NANP (Pf ) and MSP1 (Pv) were signifi-
cantly higher in people who had had malaria within the
last 10 years. This might be due to the fact of boosting
up of the immune system of these individuals when
compared to people who did not get malaria during past
10 years.Higher levels of anti-MSP1 (Pf ) and anti-AMA1 (Pv)
antibodies were observed among the individuals within
the age group 45–59 years compared to other age groups
of the community. An increase of sero-prevalence could
also be observed up to this age. Such age-related
trends in anti-P. falciparum antibody levels have been
observed by many workers in diverse population
groups at high [14,15] and even at low malaria trans-
mission levels [16]. Total IgE levels of males were sig-
nificantly higher than in females in the present study.
Many population studies have revealed the sexual di-
morphism of total IgE levels for reasons that remain
unclear [17,18]. In the present study however, the par-
ticular population is an agricultural community; the
Figure 2 Pair-wise linkage disequilibrium (LD) plots of the significant single nucleotide polymorphisms of Chromosome 1 (Figure 2a),
Chromosome 5 (Figure 2b) and Chromosome 11 (Figure 2c). The numbers in each box represents 100 x D’ value. Red squares indicate pairs
of SNPs in high linkage (D’~ 1.00). The plots were generated using Haploview software.
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fields (compared to women, who engage in fewer out-
door activities) exposing themselves to allergens and/or
antigens, that induce high levels of IgE, which play an
important role in allergy and are especially associated
with type I hypersensitivity [19].
It was interesting to note that the residents in village
Akkarawissa had notably higher antibody levels than
did the residents of the other seven villages. Akkara-
wissa is a farming village its residents mainly focusing
on “Chena cultivation” where they burn the patches of
jungles to cultivate their crops and its people areknown to spend considerable amounts of time in the
cultivation areas in the middle of the jungles, com-
pared to other villagers. It is also surrounded by foli-
age that gives refuge to mosquitoes and other insects.
Therefore, it is likely that there is higher exposure to
malaria among the residents of this particular area al-
though there was no significant difference between the
numbers of past malaria attacks as recalled by these
residents when compared to others. In-depth epi-
demiological studies would need to be carried out to
prove (or disprove) the likelihood of increase exposure
to malaria by these individuals.
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were found to be in association with the high levels of
anti–malarial antibodies (Chi squared test, p < 0.05).
Polymorphism rs1801274 in FCGR2A was associated
with elevated levels of anti–MSP1 (Pv). A study done in
two ethnic groups in Mali has shown the same poly-
morphism that had an influence on P. falciparum react-
ive IgG levels, which was related to protection against
malaria [20]. A study based in India has revealed that
homozygotes for the polymorphisms rs1801274 corre-
lated with susceptibility to severe falciparum malaria
[21]. It was suggested by Parren et al. in 1992 that this
polymorphism could affect the regulation of the IgG
subclass production or turnover in humans [22]. There-
fore, rs1801274 appears to be a polymorphism that is of
distinct interest in malaria immunology and warrants
further investigations.
A case–control study of malaria based on some ethnic
groups in Sudan has revealed significant differences in
genotype distribution among cases and controls of the
polymorphisms rs10775349 and rs22443250 [23]. Both
these SNPs were found to correlate with elevated anti-
bodies in the study population: rs10775349 associated
with anti–MSP1 for P. vivax and rs22443250 with total
IgE levels.
Both rs1800871 and rs1800872 SNPs were signifi-
cantly associated with elevated antibody levels against
the NANP antigen of P. falciparum and were in
complete linkage disequilibrium. Several investigators
have reported that polymorphisms in rs1800872 IL10
promoter sequence increase the promoter activity
with resultant high levels of IL10 production [24,25].
A study done in a Thai population revealed that the
SNP rs1881457, which is located in the same haplotype
block in 5q31-33 region with the RAD50 gene and the
promoter of IL13 is significantly associated with severe
falciparum malaria [26]. The present study shows that
this particular SNP is associated with high levels of anti-
AMA1 and anti-NANP for P. falciparum; these findings
of the two studies regarding rs1881457 are difficult to
reconcile.Conclusion
Age-acquired immunity to malaria (up to 59 years)
seems to prevail in this low malaria transmission area
of Sri Lanka; this is likely to be due to repeated ex-
posure to infection (probably less frequent and even
subclinical) over the years. Evidence point towards
the presence of host-genetic variants that might have
links with the generation and/or maintenance of anti-
malarial antibodies that are maintained at high levels
in this population inspite of the low incidence of mal-
aria reported. No definite genetic clues could befound that favour susceptibility or protection against
malaria infections. The suggested influence of the
tested genetic markers on anti-malarial antibody levels
could be either an individual or a combined effect
since some of the markers were seen to be in linkage
disequilibrium.
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